Temasek Invests in Mexican Clinical Diagnostics Company
Posted on 06/27/2018
On June 12, 2018, Singapore’s Temasek Holdings and LIV Capital combined acquired a 32% stake in Grupo Diagnóstico Médico Proa, S.A. de C.V., a Mexican clinical diagnostics company. Grupo Diagnóstico Médico Proa is headquartered in Mexico City and owns Laboratorios Chopo. Grupo Diagnóstico Médico Proa was formed in 1948 by Dr. Carlos Pérez Moreno. The […]
